Co-existence of <em>BRAF<sup>V600E</sup></em> and <em>TERT </em>promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis

Abstract

The current study demonstrated that the coexistence of <i>BRAF</i> and <i>TERT</i> promoter mutations were associated with the PTC aggressiveness, although these mutations were not associated with PTC lymph node metastasis or with PTMC.